Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Revision History For: BIOMIRA RESEARCH (BIOM)

No earlier versions found for this Subject.

Return to BIOMIRA RESEARCH (BIOM)

Biomira (BIOM) is a Canadian biotechnology company that is spearheading research on cancer vaccines. They have a rich pipeline of products designed to stimulate the immune system--helping the body fight cancer.

Their products can be used in conjunction with other therapies such as surgery, chemotherapy, and radiation and appear to have minimal side effects compared to traditional therapies.

This thread is not for general discussion. Only post information that helps investors understand Biomira and their fascinating research.